Hegseth’s Testosterone Screening Policy Sparks Medical Concerns
Wertynews.com – Following the announcement by Defense Secretary Pete Hegseth that U.S. military personnel aged 30 and older will undergo annual checks for “testosterone deficiency,” medical experts have voiced reservations about the initiative’s purpose and implementation. Hegseth emphasized that the policy aims to ensure service members maintain optimal hormonal levels as part of routine health evaluations, with younger personnel offered the choice to participate. The goal, he stated, is to help individuals “operate at their absolute best” by addressing potential testosterone imbalances. However, the policy’s broader implications for female service members and its specific criteria remain unclear.
Testosterone Levels and Their Fluctuations
Testosterone, a hormone produced naturally by the body, plays a role in muscle and bone maintenance, mood regulation, and energy levels. While it also influences libido and sperm production in men, its connection to combat readiness or physical performance is debated. Dr. Marcus Goncalves, a specialist in endocrinology, explained that testosterone levels can vary significantly based on age, lifestyle, and even the time of day. “Normal ranges span from 270 to 900-plus,” he noted. “Someone could be within the normal range at 350, while another might be at 650. Neither level inherently correlates with masculinity or perceived strength.”
“Testosterone in the normal range is not a performance drug,” said Dr. Céline Gounder, CBS News medical correspondent. “For a man with genuinely low levels, replacement therapy can offer minor benefits in libido and mood. However, it hasn’t been proven to enhance cognitive function, combat fatigue, or improve a healthy 30-year-old’s military effectiveness.”
According to Goncalves, factors such as stress, inadequate sleep, and overexertion can temporarily lower testosterone levels. These conditions, common among service members, often cause “transient and reversible” drops. “When the situation changes, the hormone naturally rebounds,” he said. Researchers have observed that military training can affect testosterone, but such fluctuations are typically short-lived.
Cost and Complexity of the Screening Process
Medical professionals highlighted the logistical and financial challenges of the proposed screening. Testosterone testing requires precise timing, as levels fluctuate throughout the day. Goncalves recommended testing between 8 and 10 a.m., when testosterone is typically at its peak. “Ideally, individuals should fast before the test,” he added. “A single measurement isn’t sufficient—repeating the test is essential for accurate diagnosis.”
“There’s no published analysis showing this is a cost-effective measure,” Gounder remarked. “The Endocrine Society examined the same issue, and their findings suggest general screenings may not justify the investment. Without clear evidence of performance gains, the policy risks becoming a costly routine rather than a targeted solution.”
The process of diagnosing low testosterone involves multiple appointments and tests over several months, according to experts. Gounder estimated that blood draws alone would cost the military “tens of millions annually,” with follow-up care and monitoring further increasing expenses. She argued that the policy’s financial burden could be significant, especially for an administration focused on minimizing waste and fraud.
Broader Implications and Questions Remain
While the policy targets “testosterone deficiency,” Gounder pointed out that low levels are often linked to other factors, such as weight gain, opioid use, or chronic stress. “These are common in military life,” she said. “Treating the underlying cause is more effective than merely adjusting hormone levels.” She also noted that symptoms like fatigue and poor concentration can stem from “20 other conditions,” making broad screening potentially misleading.
As details of the policy continue to emerge, the debate over its necessity and impact on service members’ health and readiness remains ongoing. The Endocrine Society and the American College of Physicians have previously advised against routine testosterone testing, citing the hormone’s natural variability and the lack of conclusive evidence linking it to enhanced performance. For now, the medical community awaits further clarification on how the policy will be applied and its long-term consequences.
